The order carried out with reference to the application process for the grant titled:
SARCO: PRECLINICAL AND CLINICAL DEVELOPMENT OF SMALL MOLECULE OATD-01, A DRUG CANDIDATE FOR THE TREATMENT OF SARCOIDOSIS
co-financed by the National and European Union Funds through the sectoral programme InnoNeuroPharm (Call for proposals 3/1.2/2018) and because of the competitiveness principle.
We hereby look for Contractor ready to perform the service:
Execution of the developmental and reproductive toxicology studies program for the chitinase inhibitor OATD-01, developed as an innovative treatment for sarcoidosis